Patent · US Active

Adamantane or pinene derivatives for use in the treatment of chlamydiales infections

US10039727B2 · kind B2 · utility

0Cited by

0References

15Claims

0Family size

Assignee

COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES · FR

Inventors

Daniel Gillet · Paris, FR
Julien Barbier · San Francisco, US
Jean-Christophe Cintrat · Igny, FR
Valérie Pons · Marcoussis, FR
Thomas Rudel · Berlin, DE
Jo-Ana Herweg · Coburg, DE
Annette Fischer · Würzburg, DE

Key dates

Filing date	Apr 20, 2016
Grant date	Aug 7, 2018
Priority date	—
Expiry date	Apr 20, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2602/40
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a method for treating a Chlamydiales infection comprising the administration of a therapeutically effective amount of a compound of formula (I) to a subject in need thereof: W-L1-NH-L2-Ar (I) Wherein W, L1, L2 and Ar are as defined in claim 1.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.